We're a public biotech company (Nasdaq: ABP) leveraging our proprietary DiversImmune® and MultiMab platforms to advance next-generation antibody therapeutics for immuno-oncology and ophthalmology. Collaborating with global pharmaceutical and research partners, we're advancing a robust pipeline of innovative treatments. For more information, please visit https://abpro.co/
Looking for a particular Abpro employee's phone or email?
The Abpro annual revenue was $2 million in 2026.
Ian Chan is the Co-Founder and Board Member of Abpro.
13 people are employed at Abpro.
Abpro is based in Woburn, Massachusetts.
The NAICS codes for Abpro are [541711, 54, 5417, 54171, 541].
The SIC codes for Abpro are [873, 87].